Hannah Rush
Impact in
-
- COVID-19 and healthcare impacts
- Viral-associated cancers and disorders
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Prostate Cancer Treatment and Research 8
- Renal cell carcinoma treatment 2
- Oncology 9
- Cancer Treatment and Pharmacology 4
- Cancer Immunotherapy and Biomarkers 3
- COVID-19 and healthcare impacts 2
- Co-authors
- Paul J. Ross (1 shared paper)Chara Stavraka (1 shared paper)David P. Dearnaley (5 shared papers)Muhammad Naveed Anwar (2 shared papers)John Bridgewater (1 shared paper)Aun Muhammad (2 shared papers)Mahesh Parmar (5 shared papers)Duncan C. Gilbert (6 shared papers)
- Journals
- Annals of Oncology (6 papers)Journal of Clinical Oncology (3 papers)European Journal of Cancer (2 papers)Clinical Orthopaedics and Related Research (1 paper)Therapeutic Advances in Medical Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Hannah Rush
14 papers receiving 177 citations
Peers
Comparison fields: 5 of 30
- Oncology 62
- Hepatology 16
- Cancer Research 29
- Pulmonary and Respiratory Medicine 59
- Surgery 76
Countries citing papers authored by Hannah Rush
This map shows the geographic impact of Hannah Rush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Rush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Rush more than expected).
Fields of papers citing papers by Hannah Rush
This network shows the impact of papers produced by Hannah Rush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Rush. The network helps show where Hannah Rush may publish in the future.
Co-authors
The 25 scholars most cited alongside Hannah Rush, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 98 | |
| 2 | 2020 | 31 | |
| 3 | 2020 | 15 | |
| 4 | 2020 | 14 | |
| 5 | 2019 | 5 | |
| 6 | 2019 | 4 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 2 | |
| 9 | 2025 | 1 | |
| 10 | 2025 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2020 | 1 | |
| 13 | 2016 | 1 | |
| 14 | 2017 | 1 | |
| 15 | 2025 | 0 | |
| 16 | 2020 | 0 | |
| 17 | 1986 | 0 | |
| 18 | 2018 | 0 |
About Hannah Rush
Hannah Rush is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Surgery, having authored 18 papers that have together received 178 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Renal cell carcinoma treatment (2 papers), COVID-19 and healthcare impacts (2 papers), Hormonal and reproductive studies (2 papers) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (62 citations), Hepatology (16 citations), Cancer Research (29 citations), Pulmonary and Respiratory Medicine (59 citations) and Surgery (76 citations). Hannah Rush has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Paul J. Ross, Chara Stavraka, David P. Dearnaley, Muhammad Naveed Anwar, John Bridgewater, Aun Muhammad, Mahesh Parmar, Duncan C. Gilbert, Fharat Raja and Khurum Khan. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, European Journal of Cancer, Clinical Orthopaedics and Related Research and Therapeutic Advances in Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.